Interpretation of results of chemotherapy trials in metastatic breast cancer.
出版信息
J Clin Oncol. 1986 Feb;4(2):258-61. doi: 10.1200/JCO.1986.4.2.258.
PMID:3511185
Abstract
摘要
相似文献
1
Interpretation of results of chemotherapy trials in metastatic breast cancer.
J Clin Oncol. 1986 Feb;4(2):258-61. doi: 10.1200/JCO.1986.4.2.258.
2
[Metastatic cancer of the breast. Study of intensive induction of remission chemotherapy. Controlled clinical trial].
Bull Cancer. 1986;73(6):683-4.
3
Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Chemioterapia. 1987 Jun;6(2 Suppl):712-3.
4
CAF in metastatic breast cancer: standard therapy or another effective regimen?
J Clin Oncol. 1987 Oct;5(10):1497-9. doi: 10.1200/JCO.1987.5.10.1497.
5
Dose intensity in chemotherapy of metastatic breast cancer.
J Clin Oncol. 1985 Jun;3(6):889-91. doi: 10.1200/JCO.1985.3.6.889.
6
RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.
Clin Breast Cancer. 2008 Aug;8(4):370-3. doi: 10.3816/CBC.2008.n.045.
7
[Chemotherapy of primary and metastasizing breast cancer].
Gynakol Rundsch. 1984;24 Suppl 1:78-86.
8
Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?
Clin Cancer Res. 2008 Nov 1;14(21):6725-9. doi: 10.1158/1078-0432.CCR-07-4704.
9
Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint.
Breast Cancer Res Treat. 2010 Jul;122(1):9-10. doi: 10.1007/s10549-010-0919-7. Epub 2010 May 22.
10
Hexamethylmelamine use in the treatment of metastatic breast cancer.
Cancer Treat Rev. 1991 Mar;18 Suppl A:91-8. doi: 10.1016/0305-7372(91)90029-y.
引用本文的文献
1
Postmenopausal breast cancer. Drug therapy in the 1990s.
Drugs Aging. 1993 Mar-Apr;3(2):106-21. doi: 10.2165/00002512-199303020-00002.
Zotero 插件